AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2013
Jun 4, 2013
30016_dirs_2013-06-04_73cb9d8b-04ff-4bed-b677-3758d4c46e0f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-06-01
Reporting Person: Williams Michael J PhD (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-06-01 | Common Stock | M | 1299 | — | Acquired | 11354 | Direct |
| 2013-06-01 | Common Stock | F | 655 | $82.44 | Disposed | 10699 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-06-01 | Restricted Stock Unit | $ | M | 1299 | Disposed | Common Stock (1299) | Direct |
Footnotes
F1: Includes 66 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 03/29/2013.
F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (06/01/2012) of the date of grant.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 26